GE HealthCare Technologies (GEHC) Stock Price, News & Analysis

Company Overview

GE HealthCare Technologies (NASDAQ: GEHC) is a global medical technology and diagnostics company that develops, manufactures and markets a broad range of products and services for healthcare providers. Its portfolio centers on diagnostic imaging systems, including MRI, CT, PET and X-ray modalities, as well as ultrasound equipment. The company also supplies patient monitoring and anesthesia delivery systems, interventional and surgical imaging solutions, and molecular imaging technologies used in both clinical care and research settings.

In addition to hardware, GE HealthCare offers software, analytics and lifecycle services aimed at improving clinical workflows and equipment uptime. The company has invested in digital platforms and artificial intelligence tools designed to aggregate imaging and clinical data, support diagnostic decision-making and optimize operational performance. It also provides installation, maintenance, training and managed services to help hospitals and clinics manage capital assets and clinical operations across the equipment lifecycle.

GE HealthCare was previously the healthcare unit of General Electric and became an independent, publicly traded company in early 2023 following a corporate separation. The business has a long-standing presence in healthcare technology and continues to serve customers worldwide, including hospitals, outpatient centers, research institutions and specialty clinics across the Americas, Europe and the Asia-Pacific region. At the time of the separation, Kieran Murphy, who led the healthcare division within GE, continued as chief executive of the standalone company.

The company’s strategic focus emphasizes diagnostic excellence, digital transformation and service delivery to support value-based care initiatives. GE HealthCare positions its products and software to help clinicians accelerate diagnosis, improve patient throughput and reduce costs, while pursuing partnerships and R&D efforts to expand its clinical applications and global footprint.

Key Stats

• Today's Range: $64.77 to $66.41
• 50-Day Range: $59.49 to $74.67
• 52-Week Range: $58.75 to $89.77
• Volume: 3.97 million shs
• Average Volume: 4.28 million shs
• Market Capitalization: $30.05 billion
• P/E Ratio: 15.80
• Dividend Yield: 0.21%
• Price Target: $80.21
• Consensus Rating: Moderate Buy

GE HealthCare Technologies Stock Analysis - MarketRank™

GE HealthCare Technologies scored higher than 97% of companies evaluated by MarketBeat, and ranked 7th out of 865 stocks in the medical sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 3.9 / 5
• Analyst Rating: Moderate Buy

Consensus Rating

GE HealthCare Technologies has received a consensus rating of Moderate Buy. The company's average rating score is 2.50, and is based on no strong buy ratings, 9 buy ratings, 9 hold ratings, and no sell ratings.

Upside Potential

GE HealthCare Technologies has a consensus price target of $80.21, representing about 20.9% upside from its current price of $66.33.

Amount of Analyst Coverage

GE HealthCare Technologies has been the subject of 13 research reports in the past 90 days, demonstrating strong analyst interest in this stock.

Earnings and Valuation

• Score: 2.5 / 5
• Proj. Earnings Growth: 10.02%

Earnings Growth

Earnings for GE HealthCare Technologies are expected to grow by 10.02% in the coming year, from $4.89 to $5.38 per share.

Price to Earnings Ratio vs. the Market

The P/E ratio of GE HealthCare Technologies is 15.80, which means that it is trading at a less expensive P/E ratio than the market average P/E ratio of about 38.73.

Price to Earnings Ratio vs. Sector

The P/E ratio of GE HealthCare Technologies is 15.80, which means that it is trading at a less expensive P/E ratio than the Medical sector average P/E ratio of about 23.98.

Price to Earnings Growth Ratio

GE HealthCare Technologies has a PEG Ratio of 1.46. PEG Ratios above 1 indicate that a company could be overvalued.

Price to Book Value per Share Ratio

GE HealthCare Technologies has a P/B Ratio of 2.91. P/B Ratios below 3 indicates that a company is reasonably valued with respect to its assets and liabilities.

Short Interest

• Score: 3.0 / 5
• Short Interest Level: Healthy

Percentage of Shares Shorted

2.69% of the float of GE HealthCare Technologies has been sold short.

Short Interest Ratio / Days to Cover

GE HealthCare Technologies has a short interest ratio ("days to cover") of 1.98, which is generally considered an acceptable ratio of short interest to trading volume.

Change versus previous month

Short interest in GE HealthCare Technologies has recently increased by 0.97%, indicating that investor sentiment is decreasing.

Dividend

• Score: 1.7 / 5
• Dividend Strength: Weak

Dividend Yield

GE HealthCare Technologies has a dividend yield of 0.22%, which is in the bottom 25% of all stocks that pay dividends.

Dividend Growth

GE HealthCare Technologies has only been increasing its dividend for 1 years.

Dividend Coverage

The dividend payout ratio of GE HealthCare Technologies is 3.35%. This payout ratio is at a healthy, sustainable level, below 75%.

Dividend Sustainability

Based on earnings estimates, GE HealthCare Technologies will have a dividend payout ratio of 2.60% next year. This indicates that GE HealthCare Technologies will be able to sustain or increase its dividend.

News and Social Media

• Score: 3.8 / 5
• News Sentiment: 1.04

News Sentiment

GE HealthCare Technologies has a news sentiment score of 1.04. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.49 average news sentiment score of Medical companies.

News Coverage This Week

MarketBeat has tracked 15 news articles for GE HealthCare Technologies this week, compared to 7 articles on an average week.

Search Interest

Only 36 people have searched for GEHC on MarketBeat in the last 30 days. This is a decrease of -18% compared to the previous 30 days.

MarketBeat Follows

13 people have added GE HealthCare Technologies to their MarketBeat watchlist in the last 30 days. This is an increase of 86% compared to the previous 30 days.

Company Ownership

• Score: 3.6 / 5
• Insider Trading: Acquiring Shares

Cluster Insider Buying

6 insiders have purchased shares of GE HealthCare Technologies in the last three months. Multiple insiders buying is a strong bullish signal.

Net Insider Buying

Over the last three months, insiders have purchased a net $1,361,355.00 in company stock, which represents 0.0045% of the company's market cap.

Insider Buying vs. Insider Selling

In the past three months, GE HealthCare Technologies insiders have bought more of their company's stock than they have sold. Specifically, they have bought $1,361,355.00 in company stock and sold $0.00 in company stock.

Percentage Held by Insiders

0.36% of the stock of GE HealthCare Technologies is held by insiders.

Percentage Held by Institutions

82.06% of the stock of GE HealthCare Technologies is held by institutions. High institutional ownership can be a signal of strong market trust in this company.

Company Calendar

• Ex-Dividend for 5/15 Dividend: 4/02/2026
• Record date for 5/15 Dividend: 4/03/2026
• Last Earnings: 4/29/2026
• Dividend Payable: 5/15/2026
• Today: 6/09/2026
• Next Earnings (Estimated): 7/29/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: Medical
• Industry: MED PRODUCTS
• Sub-Industry: Medical Equipment
• Current Symbol: NASDAQ:GEHC
• Previous Symbol: NASDAQ:GEHC
• CIK: 1932393
• Web: www.gehealthcare.com
• Phone: 833-735-1139
• Fax: N/A
• Employees: 54,000
• Year Founded: 1994

Price Target and Rating

• Average Price Target for GE HealthCare Technologies: $80.21
• High Price Target: $98.00
• Low Price Target: $65.00
• Potential Upside/Downside: +21.1%
• Consensus Rating: Moderate Buy
• Rating Score (0-4): 2.50
• Research Coverage: 18 Analysts

Profitability

• EPS (Trailing Twelve Months): $4.18
• Trailing P/E Ratio: 15.85
• Forward P/E Ratio: 13.55
• P/E Growth: 1.46
• Net Income: $2.08 billion
• Net Margins: 9.10%
• Pretax Margin: 12.30%
• Return on Equity: 20.46%
• Return on Assets: 5.73%

Debt

• Debt-to-Equity Ratio: 0.95
• Current Ratio: 1.22
• Quick Ratio: 0.95

Sales & Book Value

• Annual Sales: $20.98 billion
• Price / Sales: 1.44
• Cash Flow: $6.02 per share
• Price / Cash Flow: 11.01
• Book Value: $22.80 per share
• Price / Book: 2.91

Miscellaneous

• Outstanding Shares: 454,892,000
• Free Float: 453,254,000
• Market Cap: $30.13 billion
• Optionable: Optionable
• Beta: 0.74